Freimut Schliess
Neuss, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
The German Fast Track Toward Reimbursement of Digital Health Applications: Opportunities and Challenges for Manufacturers, Healthcare Providers, and People With Diabetes.
Journal: Journal of diabetes science and technology
Published: September 05, 2022
TIGER: technical variation elimination for metabolomics data using ensemble learning architecture.
Journal: Briefings in bioinformatics
Published: September 08, 2021
Validation of Candidate Phospholipid Biomarkers of Chronic Kidney Disease in Hyperglycemic Individuals and Their Organ-Specific Exploration in Leptin Receptor-Deficient db/db Mouse.
Journal: Metabolites
Published: December 15, 2020
Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studies.
Journal: BMC health services research
Published: July 10, 2020
Integrated personalized diabetes management goes Europe: A multi-disciplinary approach to innovating type 2 diabetes care in Europe.
Journal: Primary care diabetes
Published: July 09, 2020
Machine Learning Approaches Reveal Metabolic Signatures of Incident Chronic Kidney Disease in Individuals With Prediabetes and Type 2 Diabetes.
Journal: Diabetes
Published: June 03, 2020
Effects of sequential treatment with lixisenatide, insulin glargine, or their combination on meal-related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: October 14, 2019
Artificial Pancreas Systems for People With Type 2 Diabetes: Conception and Design of the European CLOSE Project.
Journal: Journal of diabetes science and technology
Published: September 23, 2018
Impact of insulin glargine and lixisenatide on β-cell function in patients with type 2 diabetes mellitus: A randomized open-label study.
Journal: Diabetes, obesity & metabolism
Published: February 03, 2017
Effects of dextromethorphan as add-on to sitagliptin on blood glucose and serum insulin concentrations in individuals with type 2 diabetes mellitus: a randomized, placebo-controlled, double-blinded, multiple crossover, single-dose clinical trial.
Journal: Diabetes, obesity & metabolism
Published: August 18, 2015
Metabolic consequences of acute and chronic empagliflozin administration in treatment-naive and metformin pretreated patients with type 2 diabetes.
Journal: Diabetologia
Published: July 22, 2015
Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment.
Journal: Nature medicine
Published: October 29, 2014
Last Updated: 09/26/2026